The Down Under medical community is abuzz with the arrival of retatrutide, a novel dual GIP and GLP-1 medication showing significant results in early trials for addressing obesity. This therapy promises a https://auresortwear.com/2026/06/10/retatrutide-australia-my-deep-dive-into-weight-loss-treatments/